Expression Table for this CRE
| CNhs14498 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2 | 176.5 |
| CNhs14191 | Smooth muscle cells - airway, control, donor2 | 10.8 |
| CNhs14224 | substantia nigra, adult, donor10258 | 9.0 |
| CNhs12730 | Mesenchymal Stem Cells - hepatic, donor2 | 8.7 |
| CNhs14407 | 293SLAM rinderpest infection, 00hr, biol_rep2 | 8.0 |
| CNhs12394 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13) | 5.3 |
| CNhs14436 | COBL-a rinderpest(-C) infection, 06hr, biol_rep2 | 5.3 |
| CNhs14434 | COBL-a rinderpest infection, 48hr, biol_rep3 | 5.3 |
| CNhs12516 | Adipocyte differentiation, day04, donor1 | 5.0 |
| CNhs14519 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1 | 4.9 |
| CNhs12420 | MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1 | 4.7 |
| CNhs14082 | globus pallidus, newborn, donor10223 | 4.6 |
| CNhs12054 | Bronchial Epithelial Cell, donor4 | 4.6 |
| CNhs13469 | CD14+ monocytes - treated with Group A streptococci, donor1 | 4.0 |
| CNhs12756 | MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3 | 3.9 |
| CNhs12700 | K562 erythroblastic leukemia response to hemin, day02, biol_rep2 | 3.6 |
| CNhs12517 | Adipocyte differentiation, day08, donor1 | 3.0 |
| CNhs14494 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1 | 3.0 |
| CNhs12998 | testis, adult, pool2 | 3.0 |
| CNhs12075 | Hepatic Sinusoidal Endothelial Cells, donor1 | 2.9 |
| CNhs12019 | Nucleus Pulposus Cell, donor2 | 2.8 |
| CNhs14376 | mesothelioma cell line:Mero-14 | 2.5 |
| CNhs12367 | mesenchymal precursor cell - bone marrow, donor2 | 2.5 |
| CNhs13474 | CD14+ monocytes - treated with B-glucan, donor1 | 2.4 |
| CNhs12663 | MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 2.4 |
| CNhs14223 | thalamus, adult, donor10258 | 2.4 |
| CNhs13831 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 2.4 |
| CNhs14488 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1 | 2.3 |
| CNhs12518 | common myeloid progenitor CMP, donor1 | 2.3 |
| CNhs13830 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1 | 2.3 |
| CNhi10525_AGT | Human primary dermal fibroblasts derived from neonatal foreskin, biol_rep1 | 2.3 |
| CNhs13836 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1 | 2.2 |
| CNhs13845 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 2.2 |
| CNhs13840 | iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2 | 2.1 |
| CNhs13337 | mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1 | 2.0 |
| CNhs11837 | transitional cell carcinoma cell line:Hs 769.T | 2.0 |
| CNhs12654 | MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 2.0 |
| CNhs14221 | medial frontal gyrus, adult, donor10258 | 1.9 |
| CNhs14493 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3 | 1.9 |
| CNhs14239 | epithelioid sarcoma cell line:HS-ES-2R | 1.9 |
| CNhs12653 | MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2 | 1.9 |
| CNhs11371 | Adipocyte - subcutaneous, donor2 | 1.9 |
| CNhs12506 | chorionic membrane cells, donor2 | 1.9 |
| CNhs12665 | MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2 | 1.8 |
| CNhs14573 | Myoblast differentiation to myotubes, day06, control donor2 | 1.8 |
| CNhs13835 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1 | 1.8 |
| CNhs14195 | Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17) | 1.8 |
| CNhs12088 | Renal Epithelial Cells, donor2 | 1.8 |
| CNhs12657 | MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 1.8 |
| CNhs14432 | COBL-a rinderpest infection, 48hr, biol_rep2 | 1.7 |